Angina Market to Grow 6.3% Globally Through 2030, Though Pandemic and War Could Disrupt Growth
-
The global Angina market is projected to grow at a CAGR of 6.3% from 2023 to 2030 due to rising prevalence of cardiovascular diseases.
-
North America currently dominates the Angina market but Asia Pacific is expected to witness the highest growth rate in coming years.
-
Key companies in the market include Amgen, Taxus Cardium Pharmaceuticals, LegoChem Biosciences, Lee’s Pharmaceutical, and others.
-
The market offers opportunities for medications like beta blockers, calcium antagonists, anticoagulants, antiplatelets, nitrates, ACE inhibitors, and ranolazine.
-
The COVID-19 pandemic and Russia-Ukraine war may disrupt supply chains and divert medical resources, impacting Angina market growth.